APX005M treatment for recurrent or refractory primary malignant CNS tumor patients
PBTC-051
Phase 1 mab active
Quick answer
APX005M treatment for recurrent or refractory primary malignant CNS tumor patients for Glioblastoma Multiforme is a Phase 1 program (mab) at Pyxis Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pyxis Oncology
- Indication
- Glioblastoma Multiforme
- Phase
- Phase 1
- Modality
- mab
- Status
- active